L. Nagy, Á. Kov́acs, B. Bódi
Sep 1, 2015
Citations
6
Influential Citations
77
Citations
Quality indicators
Journal
British Journal of Pharmacology
Abstract
Omecamtiv mecarbil (OM) is a novel cardiac myosin activator drug for inotropic support in systolic heart failure. Here we have assessed the concentration‐dependent mechanical effects of OM in permeabilized cardiomyocyte‐sized preparations and single skeletal muscle fibres of Wistar‐Kyoto rats under isometric conditions.